Seradyn Quantitative Microsphere System Lamotrigine Immunoassay on a Hitachi 911 Analyzer Compared With HPLC-UV

Perucca, 1996, The new generation of antiepileptic drugs: advantages and disadvantages., Br J Clin Pharmacol, 42, 531, 10.1111/j.1365-2125.1996.tb00046.x

Perucca, 1999, Monotherapy trials with the new antiepileptic drugs: study designs, practical relevance and ethical implications., Epilepsy Res, 33, 247, 10.1016/S0920-1211(98)00095-3

Vauzelle-Kervredan, 1996, Influence of concurrent antiepileptic medication on the pharmacokinetics of lamotrigine as add-on therapy in epileptic children., Br J Clin Pharmacol, 41, 325, 10.1046/j.1365-2125.1996.31610.x

Rowland, 2006, In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction., Drug Metab Dispos, 34, 1055, 10.1124/dmd.106.009340

Kilpatrick, 1996, Concentration-effect and concentration-toxicity relations with lamotrigine: a prospective study., Epilepsia, 37, 534, 10.1111/j.1528-1157.1996.tb00605.x

Black, 2000, Seizure free with lamotrigine for refractory epilepsy., Epilepsia, 41, 72

Schapel, 1996, Combination vigabatrin and lamotrigine therapy for intractable epilepsy., Seizure, 5, 51, 10.1016/S1059-1311(96)80063-X

Morris, 1998, Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service., Br J Clin Pharmacol, 46, 547, 10.1046/j.1365-2125.1998.00835.x

Morris, 2004, Long-term follow-up using a higher target range for lamotrigine monitoring., Ther Drug Monit, 26, 626, 10.1097/00007691-200412000-00007

Sallustio, 1997, High performance liquid chromatography quantitation of plasma lamotrigine concentrations: application measuring trough concentrations in patients with epilepsy., Ther Drug Monit, 19, 688, 10.1097/00007691-199712000-00014

Bland, 1986, Statistical methods for assessing agreement between two methods of clinical measurement., Lancet, 1, 307, 10.1016/S0140-6736(86)90837-8

Brodie, 1995, Double blinded comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy., Lancet, 345, 476, 10.1016/S0140-6736(95)90581-2